Articles

Find an Article

Filter articles

Applied Filters

Showing 1 to 10 of 251 results

SPCs: extending protection lifespan

UK20-05-2019Michael Pears and Joel Beevers

Two references to the Court of Justice of the European Union should help clarify the position on what exactly is eligible for a supplementary protection certificate, as Michael Pears and Joel Beevers of Potter Clarkson explain.

Conference preview: BIO-Europe Spring convenes in Vienna

Austria12-03-2019

The 13th annual BIO-Europe Spring 2019 global life science partnering event will be held March 25–27 in Vienna, Austria. Guadalupe Rodriguez and Kit Muller of EBD Group report.

The future of precision medicine part 4: diagnosing the diagnostic problem

UK14-02-2019Daniel Lim

The development of precision treatments must be complemented by the development of precision diagnostics, as Daniel Lim of Kirkland & Ellis explains.

Conference preview: 11th Pharma & Biotech Patent Litigation

EU, Netherlands13-12-2018

SPCs and trade secrets are just two issues set to be discussed at C5’s 11th Pharma & Biotech Patent Litigation, on February 26 and 27 in Amsterdam. LSIPR reports.

Warner-Lambert: the plausibility test for sufficiency of disclosure

UK28-11-2018Sheena Linehan

In November, the UK Supreme Court ruled that Warner-Lambert’s patent for a second medical use of pregabalin for the treatment of pain is invalid for insufficiency of disclosure. Sheena Linehan of Potter Clarkson explores the lessons for patent drafting.

Generic competition: when one door closes, another opens

EU, US26-10-2018

With several major drugs set to face generic or biosimilar competition as patent protection expires, LSIPR analyses how well prepared their manufacturers are and how badly their sales may be affected.

The future of precision medicine part 3: translation from research to the clinic

UK, US23-10-2018Daniel Lim

The implementation of precision medicine represents a huge, possibly unprecedented, challenge to conventional clinical practice across the breadth of healthcare disciplines, says Daniel Lim of Kirkland & Ellis.

Gene-editing: a block on further development

EU22-10-2018

An EU court ruling on gene-editing regulation has sparked widespread concerns in the scientific and legal communities, as LSIPR finds out.

SPC waiver: good intentions, but not the right deal?

EU17-10-2018

The European Commission’s proposed export waiver for supplementary protection certificates has exposed a number of likely flaws which have not gone down well with patent owners. LSIPR reports.

How the EPO treats personalised healthcare patents

EU12-10-2018Laurence Gainey

The patenting of personalised healthcare inventions has proved problematic in a 
number of jurisdictions, but various aspects of these inventions are patentable in Europe, as Laurence Gainey of HGF explains.

Showing 1 to 10 of 251 results

LSIPR